Enabling digital capabilities in a highly regulated environment for building Pharma 4.0

About the session

Digitalisation has enabled greater opportunities for innovation throughout the life-cycle of pharmaceutical products. There's a greater degree of connectivity and transparency, which has now imposed a closer and greater control over operations and quality, allowing faster decision-making. However, on the contrary, upgrading to Pharma 4.0 demands higher levels of security, owing to the increased vulnerability of interconnected automated systems.

See More See Less
Up Next
Up Next
Suggested stories from YourStory TV

The role of reviewable energy and how the cloud is enabling organization to take the next leap in climate action.

TheSoonicornSpotlight Episode 7: The acquisition playbook for growth and scale

Cloud and containerisation – the two Cs to agility and scale for startups

Hybrid work culture leveraging modern technology

Dr D Y Patil Pratishthan's digital transformation

The post-pandemic era: Peter Jayaseelan on reinventing how we work